UBS cuts target to USD 18.00 for Healthcare Realty Trust stock

Published on 10/17/2026 at 19:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Forecast revenue is USD 275.71 million for October 29, 2026. Healthcare Realty Trust stock closed at USD 17.48 October 16, 2026, up 0.69 percent on NYSE.

Target revision and earnings date

UBS lowered its Healthcare Realty Trust target to USD 18.00 from USD 21.00 on October 13, 2026.
Forecast revenue for the October 29, 2026 report is USD 275.71 million.
Healthcare Realty Trust stock closed at USD 17.48 on October 16, 2026, up 0.69 percent versus the prior close.
The price-to-earnings ratio was minus 66.64 on October 16, 2026.

Makroaufnahme der blauen Glasfassade eines Healthpeak Properties US42226K1051 Gebäudes mit Regentropfen — Healthpeak Properties US42226K1051 in einer Makro-Detailaufnahme der blauen Glasfassade mit feinen Wassertropfen nach Regen, Illustration mit AI erstellt.

UBS lowered its price target for Healthcare Realty Trust from USD 21.00 to USD 18.00 and maintained a neutral rating in a note dated October 13, 2026, according to MarketBeat. The new target is 2.97 percent above the USD 17.48 closing price. Healthcare Realty Trust stock closed at USD 17.48 on October 16, 2026, up 0.69 percent on the NYSE versus the prior close of October 15, 2026.

October 29 report date

Healthcare Realty Trust is estimated to report third-quarter results after the market close on October 29, 2026, with a conference call scheduled for October 30, 2026, according to MarketBeat. The same estimate puts third-quarter revenue at USD 275.71 million, compared with USD 297.77 million in the year-earlier quarter, a projected decline of 7.40 percent.

Range and trading activity

The October 16 session covered USD 17.20 to USD 17.52, while volume reached 6,641,499 shares against an average of 4,001,970. The closing price stood 7.17 percent above the 52-week low of USD 16.31 and 20.69 percent below the 52-week high of USD 22.04.

Healthcare Realty Trust reported second-quarter revenue of USD 278.58 million for the period ended June 30, 2026. Net income attributable to common shareholders was negative USD 43.51 million, and diluted earnings per share were negative USD 0.13 for that quarter.

Valuation and peer comparison

The market capitalization was USD 6.1 billion on October 16, 2026, and the price-to-earnings ratio was minus 66.64. The dividend yield was 0.05 percent, below the 0.10 percent threshold used here for a yield comparison. MarketBeat reported a consensus target of USD 21.40, which was 22.43 percent above the closing price.

Comparison with peers

Healthcare Realty Trust (NYSE, USD): plus 0.69 percent, price-to-earnings ratio minus 66.64, market capitalization USD 6.1 billion
Healthpeak Properties (NYSE, USD): plus 0.11 percent, price-to-earnings ratio 54.23, market capitalization USD 13.1 billion
Welltower (NYSE, USD): plus 0.09 percent, price-to-earnings ratio 124.26, market capitalization USD 169.2 billion

Closing level and next date

The next scheduled company event is the estimated third-quarter earnings release on October 29, 2026, followed by the conference call on October 30, 2026. The October 16 closing price of USD 17.48 leaves the stock below both the UBS target of USD 18.00 and the broader consensus target of USD 21.40.